NRGPS is positively correlated with PDCD1LG2 and HAVCR2, and the expression of PDCD1LG2 and HAVCR2 is significantly higher in GC patients in the high-NRGPS group (Figure S4A). Here, HAVCR2 is linked to gastric cancer.